MarketInOut Stock Screener Log In | Sign Up

Artrya Ltd

Healthcare • Health Information Services • Quote as of 10/29/2026 16:10
Artrya Ltd stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
Market Capitalization401.9 mln
Float130 mln
Earnings Date03/02/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.27
Reliable

1-Year Forecast

6.24
Transformational upside

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-89,936%
Severely loss-making

Business Description

Founded in West Perth in 2018, Artrya is an Australian company that has built a cloud-based software platform called Salix, which uses artificial intelligence to analyze heart scans and help doctors spot patients at risk of coronary artery disease. By automating the review of CT imaging, Salix helps medical teams identify and manage those most likely to suffer a heart attack. The company is focused on bringing this technology to market across Australia.

Key Fundamentals

EPS-0.17
ROE-39.99
RPS0.00
ROIC-233
ROA-37.55
Interest Cover-1,706
EBITDA, mln-23.91
EV / EBITDA-21.10
EV / EBIT-20.05
Revenue, mln0.03
EV / Revenue18,023

Quote Details

Last 2.73
Change 0.08 (3.02%)
Open 2.72
Volume 927,788
Turnover 2,532,861
Average Volume 1,527,365

Financial Ratios

Pre-Tax Profit Margin-89,936
Leverage Ratio1.09
Current Ratio15.72
Price / Book7.42
Price / Tangible Book7.87
Debt / Equity0.00
Price / Sales14,318

Financial Strength

Altman Z-Score47.81
Piotroski F-Score 3 / 9
Beneish M-Score-3.27
1-Year Target Price6.24

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.02% 79 / 100   
1 Month -23.31% 12 / 100   
2 Months -51.42% 2 / 100   
6 Months -39.33% 17 / 100   
1 Year -19.94% 37 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog